Free Trial

BioCryst Pharmaceuticals (BCRX) Institutional Ownership

BioCryst Pharmaceuticals logo
$7.83 +0.13 (+1.69%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

Current
Institutional Ownership
Percentage
85.88%
Number of
Institutional Buyers
(last 12 months)
87
Total
Institutional Inflows
(last 12 months)
$135.37M
Number of
Institutional Sellers
(last 12 months)
49
Total
Institutional Outflows
(last 12 months)
$58.58M
Get BCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioCryst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BCRX Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/6/2025Doliver Advisors LP74,328$559K0.2%-8.2%0.036%
12/26/2024JPMorgan Chase & Co.577,129$4.39M0.0%-22.8%0.279%
12/19/2024Principal Financial Group Inc.411,414$3.13M0.0%+1,058.1%0.199%
12/13/2024Exome Asset Management LLC196,500$1.49M1.0%N/A0.095%
11/27/2024Franklin Resources Inc.263,748$1.97M0.0%+177.8%0.127%
11/25/2024Sanctuary Advisors LLC47,389$360K0.0%+78.3%0.023%
11/21/2024SkyView Investment Advisors LLC13,000$99K0.0%+30.0%0.006%
11/18/2024Arete Wealth Advisors LLC12,050$92K0.0%-45.7%0.006%
11/16/2024Geode Capital Management LLC4,837,985$36.78M0.0%+2.7%2.336%
11/15/2024Y Intercept Hong Kong Ltd83,123$632K0.0%-7.0%0.040%
11/15/2024XTX Topco Ltd31,670$241K0.0%-79.8%0.015%
11/15/2024Wellington Management Group LLP107,820$819K0.0%N/A0.052%
11/15/2024Two Sigma Advisers LP2,181,012$16.58M0.0%+13.6%1.053%
11/15/2024State Street Corp8,849,588$67.26M0.0%-5.3%4.272%
11/15/2024Quantinno Capital Management LP10,731$82K0.0%N/A0.005%
11/15/2024Parkman Healthcare Partners LLC464,048$3.53M0.5%+15.9%0.224%
11/15/2024Jacobs Levy Equity Management Inc.367,514$2.79M0.0%-50.3%0.177%
11/15/2024Cinctive Capital Management LP273,959$2.08M0.1%N/A0.132%
11/15/2024Erste Asset Management GmbH40,000$305K0.0%N/A0.019%
11/14/2024Caligan Partners LP2,583,585$19.64M6.2%-43.8%1.247%
11/14/2024PDT Partners LLC522,280$3.97M0.4%+42.4%0.252%
11/14/2024Verition Fund Management LLC39,520$300K0.0%-72.2%0.019%
11/14/2024Captrust Financial Advisors16,274$124K0.0%+19.4%0.008%
11/14/2024Rockefeller Capital Management L.P.26,400$201K0.0%N/A0.013%
11/14/2024Alkeon Capital Management LLC7,093,822$53.91M0.1%-0.1%3.425%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC389,530$2.96M0.0%-10.0%0.188%
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank51,012$388K0.0%+7.7%0.025%
11/13/2024BNP Paribas Financial Markets496,784$3.78M0.0%+472.0%0.240%
11/13/2024FMR LLC1,988,389$15.11M0.0%+2.4%0.960%
11/13/2024The Manufacturers Life Insurance Company299,152$2.27M0.0%+40.7%0.144%
11/13/2024Dynamic Technology Lab Private Ltd11,352$86K0.0%-71.7%0.005%
11/13/2024Fisher Asset Management LLC3,338,062$25.37M0.0%+16.9%1.612%
11/12/2024Alpha DNA Investment Management LLC58,898$448K0.2%N/A0.028%
11/12/2024Algert Global LLC516,209$3.92M0.1%+46.2%0.249%
11/12/2024Charles Schwab Investment Management Inc.1,887,994$14.35M0.0%+5.8%0.912%
11/9/2024Intech Investment Management LLC54,237$412K0.0%N/A0.026%
11/8/2024Connor Clark & Lunn Investment Management Ltd.682,324$5.19M0.0%-12.8%0.330%
11/8/2024Segall Bryant & Hamill LLC1,490,376$11.33M0.2%-2.4%0.720%
11/8/2024Counterweight Ventures LLC93,384$710K0.5%+591.7%0.045%
11/6/2024KBC Group NV5,661$43K0.0%-34.4%0.003%
11/5/2024Aigen Investment Management LP28,661$218K0.0%+75.0%0.014%
11/5/2024GSA Capital Partners LLP285,588$2.17M0.2%-21.5%0.138%
11/4/2024Los Angeles Capital Management LLC86,533$658K0.0%-11.3%0.042%
10/31/2024Principal Financial Group Inc.411,414$3.13M0.0%+1,058.1%0.199%
10/28/2024Rice Hall James & Associates LLC2,163,743$16.44M0.9%+4.0%1.048%
10/25/2024China Universal Asset Management Co. Ltd.39,791$302K0.0%+64.1%0.019%
10/24/2024Semanteon Capital Management LP149,576$1.14M0.8%N/A0.072%
10/24/2024Wealth Enhancement Advisory Services LLC17,344$132K0.0%+44.5%0.008%
10/23/2024Mirae Asset Global Investments Co. Ltd.7,483$57K0.0%+21.5%0.004%
10/23/2024Assenagon Asset Management S.A.14,071$107K0.0%-78.3%0.007%
10/16/2024nVerses Capital LLC15,500$118K0.1%+52.0%0.008%
10/11/2024Creative Planning49,347$375K0.0%+5.9%0.024%
10/10/2024Inspire Investing LLC158,008$1.20M0.1%+174.6%0.077%
10/8/2024CWM LLC17,072$130K0.0%+201.7%0.008%
10/7/2024Diversified Trust Co21,680$165K0.0%-12.4%0.011%
10/3/2024SG Americas Securities LLC158,921$1.21M0.0%N/A0.077%
9/5/2024Sanctuary Advisors LLC26,571$164K0.0%N/A0.013%
8/16/2024Northeast Financial Consultants Inc65,633$406K0.0%+8.2%0.032%
8/16/2024Creative Planning46,613$288K0.0%+75.2%0.023%
8/16/2024Algert Global LLC353,133$2.18M0.1%+18.6%0.171%
8/15/2024Susquehanna Fundamental Investments LLC30,176$186K0.0%-53.1%0.015%
8/15/2024Mackenzie Financial Corp27,913$173K0.0%-13.5%0.014%
8/15/2024The Manufacturers Life Insurance Company212,581$1.31M0.0%+113.8%0.103%
8/15/2024Millennium Management LLC1,751,561$10.83M0.0%-13.8%0.849%
8/15/2024Deerfield Management Company L.P. Series C8,135,804$50.28M0.8%+62.9%3.942%
8/15/2024AQR Capital Management LLC543,241$3.36M0.0%+18.8%0.263%
8/15/2024ELCO Management Co. LLC30,792$190K0.1%-14.5%0.015%
8/15/2024Point72 Asia Singapore Pte. Ltd.72,666$449K0.1%N/A0.035%
8/15/2024Point72 Europe London LLP267,649$1.65M0.1%N/A0.130%
8/14/2024Cubist Systematic Strategies LLC1,112,232$6.87M0.0%+528.0%0.538%
8/14/2024Point72 DIFC Ltd66,564$411K0.0%+598.2%0.032%
8/14/2024Xponance Inc.12,980$80K0.0%+13.1%0.006%
8/14/2024Avoro Capital Advisors LLC12,570,000$77.68M1.0%-3.7%6.091%
8/14/2024DRW Securities LLC11,987$74K0.0%N/A0.006%
8/14/2024ProShare Advisors LLC38,128$236K0.0%-21.4%0.018%
8/14/2024Profund Advisors LLC86,815$537K0.0%-64.1%0.042%
8/12/2024Inspire Investing LLC57,550$356K0.0%-17.2%0.028%
8/12/2024XTX Topco Ltd156,946$970K0.1%+299.0%0.076%
8/12/2024Seven Eight Capital LP169,612$1.05M0.1%+1,407.1%0.082%
8/12/2024Hsbc Holdings PLC125,004$759K0.0%+32.7%0.061%
8/12/2024E Fund Management Co. Ltd.28,285$175K0.0%-61.9%0.014%
8/9/2024Renaissance Technologies LLC960,180$5.93M0.0%-39.6%0.465%
8/8/2024American Century Companies Inc.148,490$918K0.0%+896.6%0.072%
8/8/2024Rice Hall James & Associates LLC2,079,641$12.85M0.8%-3.3%1.008%
8/7/2024Headlands Technologies LLC16,750$104K0.0%N/A0.008%
8/6/2024Los Angeles Capital Management LLC97,577$603K0.0%+8.9%0.047%
8/3/2024TD Asset Management Inc240,600$1.49M0.0%N/A0.117%
8/1/2024Rhumbline Advisers318,665$1.97M0.0%+6.3%0.154%
7/31/2024nVerses Capital LLC10,200$63K0.0%N/A0.005%
7/31/2024Commonwealth Equity Services LLC143,874$889K0.0%-1.0%0.070%
7/30/2024Signaturefd LLC6,598$41K0.0%+560.5%0.003%
7/29/2024Principal Financial Group Inc.35,524$220K0.0%-26.3%0.017%
7/29/2024Panagora Asset Management Inc.650,318$4.02M0.0%+2.8%0.315%
7/27/2024Leisure Capital Management28,000$173K0.1%N/A0.014%
7/26/2024Bank of New York Mellon Corp775,957$4.80M0.0%+12.5%0.376%
7/18/2024Assenagon Asset Management S.A.64,907$401K0.0%-83.2%0.031%
7/16/2024Diversified Trust Co24,752$153K0.0%+18.0%0.012%
7/10/2024CWM LLC5,658$35K0.0%+200.0%0.003%
5/17/2024Tidal Investments LLC55,560$282K0.0%N/A0.027%
5/16/2024Redwood Investment Management LLC122,270$621K0.1%N/A0.059%
(Data available from 1/1/2016 forward)

BCRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCRX shares?

During the previous two years, 184 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($89.80M), Avoro Capital Advisors LLC ($77.68M), State Street Corp ($67.26M), Alkeon Capital Management LLC ($53.91M), Deerfield Management Company L.P. Series C ($50.28M), Pictet Asset Management SA ($46.86M), and Geode Capital Management LLC ($36.78M).Learn more on BCRX's institutional investors.

What percentage of BioCryst Pharmaceuticals stock is owned by institutional investors?

85.88% of BioCryst Pharmaceuticals stock is owned by institutional investors. Learn more on BCRX's institutional investor holdings.

Which institutional investors have been buying BioCryst Pharmaceuticals stock?

Of the 154 institutional investors that purchased BioCryst Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Kynam Capital Management LP ($5.53M), Deerfield Management Company L.P. Series C ($5.10M), Braidwell LP ($3.77M), Avoro Capital Advisors LLC ($2.87M), Assenagon Asset Management S.A. ($2.74M), Vanguard Group Inc. ($2.67M), and Prosight Management LP ($2.38M).

How much institutional buying is happening at BioCryst Pharmaceuticals?

Institutional investors have bought a total of 49,155,733 shares in the last 24 months. This purchase volume represents approximately $355.16M in transactions.

Which BioCryst Pharmaceuticals major shareholders have been selling company stock?

Of the 77 institutional investors that sold BioCryst Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($5.34M), Victory Capital Management Inc. ($4.49M), Caligan Partners LP ($2.02M), Fisher Asset Management LLC ($1.51M), Jacobs Levy Equity Management Inc. ($1.06M), Renaissance Technologies LLC ($630.20K), and BNP Paribas Financial Markets ($622.38K).

How much institutional selling is happening at BioCryst Pharmaceuticals?

Institutional investors have sold a total of 21,428,627 shares in the last 24 months. This volume of shares sold represents approximately $166.52M in transactions.



This page (NASDAQ:BCRX) was last updated on 1/6/2025 by MarketBeat.com Staff
From Our Partners